Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 101–200 of 553
The aging immune system in Alzheimer’s and Parkinson’s diseases
Heavener, K. S., & Bradshaw, E. M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00944-6 · Cited by 55
Malaguarnera, M., & Cabrera‐Pastor, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810068 · Cited by 53
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Eo, H., Kim, S., Jung, U. J., & Kim, S. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237243 · Cited by 53
Tanriöver, G., Bacioglu, M., Schweighauser, M., Mahler, J., Wegenast‐Braun, B. M., Skodras, A., Obermüller, U., Barth, M., Kronenberg‐Versteeg, D., Nilsson, K. P. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00993-8 · Cited by 53
Li, Q., Shen, C., Liu, Z., Ma, Y., Wang, J., Dong, H., Zhang, X., Wang, Z., Yu, M., Ci, L., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13094 · Cited by 51
Self-citationSun, Y.-R., Lv, Q.-K., Liu, J., Wang, F., & Liu, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106791 · Cited by 53
Circulating extracellular vesicles: friends and foes in neurodegeneration
Calvani, R., Picca, A., Guerra, F., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320972 · Cited by 51
α-Synuclein Induces Neuroinflammation Injury through the IL6ST-AS/STAT3/HIF-1α Axis
Lin, D., Zhang, H., Zhang, J., Huang, K., Chen, Y., Jing, X., & Tao, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021436 · Cited by 52
Emerging prospects of extracellular vesicles for brain disease theranostics
Wang, R., Wang, X., Zhang, Y., Zhao, H., Cui, J., Li, J., & Di, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.024 · Cited by 48
Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
Kulkarni, A. S., Burns, M. R., Brundin, P., & Wesson, D. W. (2022) · Brain Communications · doi:10.1093/braincomms/fcac165 · Cited by 49
The Role of Microglia in Brain Metastases: Mechanisms and Strategies
Feng, Y., Hu, X., Zhang, Y., & Wang, Y. (2024) · Aging and Disease · doi:10.14336/ad.2023.0514 · Cited by 51
Self-citationHuang, Q., Wang, S., Liu, Z., Rao, L., Cheng, K., & Mao, X. (2025) · Theranostics · doi:10.7150/thno.117143 · Cited by 53
Guo, Z. Y., Tang, Y., & Cheng, Y. C. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220613150814 · Cited by 49
Chib, S., & Singh, S. (2022) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2022.107124 · Cited by 48
Extracellular vesicle biomarkers for complement dysfunction in schizophrenia
Xue, T., Liu, W., Wang, L., Shi, Y., Hu, Y. C., Yang, J. Y., Li, G., Huang, H., & Cui, D. (2023) · Brain · doi:10.1093/brain/awad341 · Cited by 47
Bayati, A., & McPherson, P. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107742 · Cited by 50
Inflammasomes in neurodegenerative diseases
Wang, Q., Yang, S., Zhang, X., Zhang, S., Chen, L., Wang, W., Chen, N., & Yan, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00459-0 · Cited by 52
Role of Exosomes in Brain Diseases
Zhang, N., He, F., Li, T., Chen, J., Jiang, L., Ouyang, X.-P., & Zuo, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.743353 · Cited by 48
Si, X., Fang, Y., Li, L., Gu, L., Yin, X., Jun-Tian, Yan, Y., Pu, J., & Zhang, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113525 · Cited by 47
Differential intracellular trafficking of extracellular vesicles in microglia and astrocytes
Pantazopoulou, M., Lamprokostopoulou, A., Karampela, D. S., Alexaki, A., Delis, A. D., Coens, A., Samiotaki, M. K., Kriebardis, A. G., Melki, R., Pagakis, S. N., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04841-5 · Cited by 44
Kim, Y., Pérez‐González, R., Miller, C., Kurz, M., D’Acunzo, P., Goulbourne, C. N., & Levy, E. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03701-1 · Cited by 81
The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
Yú, L., Zhong, G., Ren, M., Sun, T., Li, Y., Ye, M., Ma, C., Guo, Y., & Liu, C. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08755-0 · Cited by 44
Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles
D’Egidio, F., Castelli, V., d’Angelo, M., Ammannito, F., Quintiliani, M., & Cimini, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106663 · Cited by 46
Recent advances in exosome-based nanodelivery systems for Parkinson's disease
Zhu, Y., Xi, Q., Liu, Y., Zhou, Y., Liao, J., & Wu, Q. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123548 · Cited by 50
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease
Yu, H., Sun, T., Wang, Z., Li, H., Xu, D., An, J., Wen, L.-L., Li, J., Li, W., & Feng, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360242 · Cited by 51
Wu, J., Li, C.-S., Huang, W., Zhou, S.-Y., Zhao, L., Li, T., Li, M., Zhang, M.-X., Qiao, C.-M., Zhao, W.-J., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.001 · Cited by 43
Extracellular Vesicles: Novel Roles in Neurological Disorders
Jin, Q., Wu, P., Zhou, X., Qian, H., & Xu, W. (2021) · Stem Cells International · doi:10.1155/2021/6640836 · Cited by 46
Sepúlveda, D., Cisternas-Olmedo, M., Arcos, J., Nassif, M., & Vidal, R. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805087 · Cited by 42
The Mechanism and Function of Glia in Parkinson's Disease
Zhang, X., Zhang, R., Awan, M. U. N., & Bai, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.903469 · Cited by 44
Miao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 42
Current insights and assumptions on α-synuclein in Lewy body disease
Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 41
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 45
Tallon, C., Picciolini, S., Yoo, S., Thomas, A. G., Pal, A., Alt, J., Carlomagno, C., Gualerzi, A., Rais, R., Haughey, N. J., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114796 · Cited by 43
Harackiewicz, O., & Grembecka, B. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2311203 · Cited by 41
LPS activates neuroinflammatory pathways to induce depression in Parkinson’s disease-like condition
Zhang, J., Xue, B., Jing, B., Tian, H., Zhang, N., Li, M., Lu, L., Chen, L., Diao, H., Chen, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961817 · Cited by 48
Milić, J., Đoković, J. B., Nikolić, I., Mitrović, J. R., Pantelić, I., Savic, S. D., & Savić, M. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020443 · Cited by 41
Targeting TREM2 for Parkinson’s Disease: Where to Go?
Li, X.-X., & Zhang, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795036 · Cited by 36
Jain, R., Vora, L. K., Nathiya, D., & Khatri, D. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05389-0 · Cited by 39
Microglia in Neurodegenerative Events—An Initiator or a Significant Other?
Harry, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115818 · Cited by 40
The chaperone Clusterin in neurodegeneration−friend or foe?
Yuste‐Checa, P., Bracher, A., & Hartl, F. U. (2022) · BioEssays · doi:10.1002/bies.202100287 · Cited by 37
Zhang, Y., Miao, Y., Xiong, X., Tan, J., Han, Z., Chen, F., Lei, P., & Zhang, Q. (2023) · Biology Direct · doi:10.1186/s13062-023-00387-5 · Cited by 37
Guo, M., Ge, X., Wang, C., Yin, Z., Jia, Z., Hu, T., Li, M., Wang, D., Han, Z., Wang, L., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040639 · Cited by 36
Self-citationBiological, diagnostic and therapeutic implications of exosomes in glioma
Davidson, C. L., Vengoji, R., Jain, M., Batra, S. K., & Shonka, N. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216592 · Cited by 38
CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases
Park, C., Weerakkody, J. S., Schneider, R., Miao, S., & Pitt, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1426700 · Cited by 35
Zhang, S., Xiang, H., Tao, Y., Li, J., Zeng, S., Xu, Q., Xiao, H., Lv, S., Song, C., Yan, C., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08869 · Cited by 35
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 39
Gabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 36
Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
Li, T., Tan, X., Li, S., Al-Nusaif, M., & Le, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.765395 · Cited by 33
Zhao, Y., Liu, J., Liu, S., Yang, P., Liang, Y., Ma, J., Mao, S., Sun, C., & Yang, Y. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.03.002 · Cited by 35
Self-citationGeerts, H., Bergeler, S., Walker, M., van der Graaf, P. H., & Courade, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41382-0 · Cited by 36
Ebrahimi, F., Kumari, A., Ghadami, S., Abdullah, S. A., & Dellinger, K. (2024) · Advanced Biology · doi:10.1002/adbi.202400623 · Cited by 34
Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods
Chen, H., Li, N., Cai, Y., Ma, C., Ye, Y., Shi, X., Guo, J., Han, Z., Liu, Y., & Wei, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00720 · Cited by 33
Mavroeidi, P., Vetsi, M., Dionysopoulou, D., & Xilouri, M. (2022) · Biomolecules · doi:10.3390/biom12070957 · Cited by 33
Jiang, T., Xu, C., Gao, S., Zhang, J., Zheng, J., Wu, X., Lu, Q., Cao, L., Yang, D., Xu, J., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00394-9 · Cited by 33
Gao, S., Jia, S., Bai, L., Li, D., & Meng, C. (2022) · Cells · doi:10.3390/cells11243956 · Cited by 34
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32
Pait, M. C., Kaye, S. D., Su, Y., Kumar, A., Singh, S., Gironda, S. C., Vincent, S., Anwar, M., Carroll, C. M., Snipes, J. A., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12398 · Cited by 34
Zeng, H., Liu, Y., Liu, X., Li, J., Lu, L., Cheng, X., Wu, X., Zhang, X., Zheng, Z., & Lu, G. (2024) · Inflammation · doi:10.1007/s10753-024-02156-6 · Cited by 35
Guo, M. A., Guan, A., Zhang, M., Li, H., Liu, W., Wu, B., Shen, W., You, T., Liang, S., Dong, Q., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107908 · Cited by 32
Self-citationGalectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
Tian, Y.-K., Ye, D.-W., Ge, M.-M., Chen, N., Zhou, Y.-Q., & Yang, H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201094547 · Cited by 31
Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications
Ouerdane, Y., Hassaballah, M. Y., Nagah, A., Ibrahim, T. M., Mohamed, H. A. H., El-Baz, A., & Attia, M. S. (2022) · Pharmaceuticals · doi:10.3390/ph15010076 · Cited by 33
The role of microglial autophagy in Parkinson’s disease
Zhu, R., Luo, Y., Li, S., & Wang, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1039780 · Cited by 34
Abe, T., Kuwahara, T., Suenaga, S., Sakurai, M., Takatori, S., & Iwatsubo, T. (2024) · iScience · doi:10.1016/j.isci.2024.108893 · Cited by 33
Zhang, Y., Li, T., Cai, X., Long, D., Wang, X., Liu, C., & Wu, Q. E. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00861-5 · Cited by 32
The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease
Conway, J. A., Kinsman, G., & Kramer, E. R. (2022) · Genes · doi:10.3390/genes13030513 · Cited by 31
Stoll, A. C., & Sortwell, C. E. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105804 · Cited by 32
Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases
Das, K., Paul, S., Mukherjee, T., Ghosh, A., Sharma, A., Shankar, P., Gupta, S. K., Keshava, S., & Parashar, D. (2023) · Cells · doi:10.3390/cells12151963 · Cited by 32
Henríquez, G., & Narayan, M. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00048 · Cited by 32
Vanherle, S., Guns, J., Loix, M., Mingneau, F., Dierckx, T., Wouters, F., Kuipers, K., Vangansewinkel, T., Wolfs, E., Lins, P. M. P., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12394 · Cited by 32
Most recent advances and applications of extracellular vesicles in tackling neurological challenges
Kaur, M., Fusco, S., den Broek, B. V., Aseervatham, J., Rostami, A. M., Iacovitti, L., Grassi, C., Łukomska, B., & Srivastava, A. K. (2024) · Medicinal Research Reviews · doi:10.1002/med.22035 · Cited by 31
Li, J., Song, J., Jia, L., Wang, M., Ji, X., Meng, R., & Zhou, D. (2024) · Biomolecules · doi:10.3390/biom14121519 · Cited by 29
Roles, Functions, and Pathological Implications of Exosomes in the Central Nervous System
Spinelli, S., Tripodi, D., Corti, N., Zocchi, E., Bruschi, M., Leoni, V., & Dominici, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031345 · Cited by 29
Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
Putri, P. H. L., Alamudi, S. H., Dong, X., & Fu, Y. L. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04374-7 · Cited by 28
Sharma, A., Muresanu, D. F., Patnaik, R., Menon, P. K., Tian, Z. R., Sahib, S., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Skaper, S. D., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.003 · Cited by 29
Wei, W., Pan, Y., Yang, X., Chen, Z., Heng, Y., Yang, B., Pu, M., Zuo, J., Lai, Z., Tang, Y., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s362865 · Cited by 29
Yan, Y., Pu, J., Zheng, R., Fang, Y., Gu, L., Guo, T., Si, X., Zhou, C., Chen, Y., Liu, Y., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15537 · Cited by 30
Jiang, Z., Wang, J., Sun, G., & Feng, M. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103784 · Cited by 28
Self-citationFallahi, S., Zangbar, H. S., Farajdokht, F., Rahbarghazi, R., Mohaddes, G., & Ghiasi, R. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14752 · Cited by 28
Overview of the Gut–Brain Axis: From Gut to Brain and Back Again
Post, Z., Manfready, R. A., & Keshavarzian, A. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771464 · Cited by 30
Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders
Bai, L., Yu, L., Ran, M., Zhong, X., Sun, M., Xu, M., Wang, Y., Yan, X., Lee, R. J., Tang, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062491 · Cited by 28
Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation
Aljohani, M. A. (2025) · Medicina · doi:10.3390/medicina61111930 · Cited by 28
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Nature’s carriers: leveraging extracellular vesicles for targeted drug delivery
Chen, Q., Zheng, Y., Jiang, X., Wang, Y., Chen, Z., & Wu, D. (2024) · Drug Delivery · doi:10.1080/10717544.2024.2361165 · Cited by 26
Li, F., Kang, X., Xin, W., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.890698 · Cited by 30
Vaz, M., Martins, T. S., & Henriques, A. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15697 · Cited by 27
Yang, Z., Wang, Y., Wei, M., Li, S., Jia, C., Cheng, C., Al‐Nusaif, M., Zhang, J., Liu, C., & Le, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05531-z · Cited by 27
Ishiguro, Y., Tsunemi, T., Shimada, T., Yoroisaka, A., Ueno, S., Takeshige‐Amano, H., Hatano, T., Inoue, Y., Saiki, S., & Hattori, N. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149620 · Cited by 26
Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition
Hussain, M., Khan, I. R., Chaudhary, M. N., Ali, K., Mushtaq, A., Jiang, B., Zheng, L., Pan, Y., Hu, J., & Zou, X. (2024) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2024.105422 · Cited by 29
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25
“Furthermore, exogenous introduction of human α-syn preformed fibrils (PFFs) into primary microglial cell cultures stimulates the release of α-syn-containing exosomes, which were fully capable of inducing protein aggregation in recipient neurons [255].”
BackgroundChemparathy, D. T., Ray, S., Ochs, C., Ferguson, N., Gawande, D. Y., Dravid, S. M., Callen, S. E., Sil, S., & Buch, S. J. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12439 · Cited by 25
Cenere, M. M., Tiberi, M., Paldino, E., D’Addario, S. L., Federici, M., Giacomet, C., Cutuli, D., Matteocci, A., Cossa, F., Zarrilli, B., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00824-w · Cited by 27
The Two Faces of Exosomes in Parkinson’s Disease: From Pathology to Therapy
Izco, M., Carlos, E., & Alvarez‐Erviti, L. (2021) · The Neuroscientist · doi:10.1177/1073858421990001 · Cited by 25
Alpha-Synuclein Handling by Microglia: Activating, Combating, and Worsening
Song, N., Chen, L., & Xie, J. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00651-6 · Cited by 25
Liu, H., Zheng, Q. Y., Yuan, J., Gao, Y., Wang, T., Zhang, H., & Li, Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101770 · Cited by 29
Onkar, A., Khan, F., Goenka, A., Rajendran, R. L., Dmello, C., Hong, C. M., Mubin, N., Gangadaran, P., & Ahn, B. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c16839 · Cited by 27
Zhang, X.-L., Gu, Y., Liu, Y.-C., Cai, Y.-T., Sun, H., Liu, M., & Liu, M. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156028 · Cited by 26
Brennan, G. P., Curran, M. M., Patterson, K. P., Luo, R., & Baram, T. Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.615802 · Cited by 27
Lai, T. T., Kim, Y. J., Nguyen, P. T., Koh, Y. H., Nguyen, T. T., Ma, H.-I., & Kim, Y. E. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.715190 · Cited by 24
Guo, S., Wang, X., Shan, D., Xiao, Y., Ju, L., Zhang, Y., Wang, G., & Qian, K. (2024) · Biomarker Research · doi:10.1186/s40364-024-00661-2 · Cited by 25
Signatures of glial activity can be detected in the CSF proteome
Eninger, T., Müller, S. A., Bacioglu, M., Schweighauser, M., Lambert, M., Maia, L. F., Neher, J. J., Hornfeck, S. M., Obermüller, U., Kleinberger, G., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119804119 · Cited by 25
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.